Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2

Status

Completed 37Unknown 7Terminated 7Recruiting 5Withdrawn 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 50Breast 48Thoracic 44Gastrointestinal 29Head & Neck 28Other solid neoplasm 9Gynecologic 9Tumor-Agnostic 5Sarcoma 3Dermatologic 2Other 1Endocrine 1

Conditions

Neoplasms 2Adenocarcinoma 2Neoplasm Metastasis 1Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 25Specimen Handling 17Blood Specimen Collection 17Biopsy 16Magnetic Resonance Spectroscopy 15atezolizumab 11Surveys and Questionnaires 11Radiosurgery 9Bevacizumab 9Paclitaxel 8Fluorouracil 8Standard of Care 7Radiotherapy 7Nivolumab 7Irinotecan 7Gemcitabine 7Cisplatin 7Carboplatin 7olaparib 6durvalumab 6Palliative Care 6Oxaliplatin 6Leucovorin 6Cyclophosphamide 6Capecitabine 6alectinib 5abemaciclib 5Trastuzumab 5Interviews as Topic 5Exercise 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Docetaxel × Tumor-Agnostic × Clear all
NCT05382559 2026-04-14

A Study of ASP3082 in Adults With Advanced Solid Tumors

Astellas Pharma Inc

Phase 1 Recruiting
681 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT05999994 2026-03-27

CAMPFIRE

Eli Lilly and Company

Phase 2 Recruiting
105 enrolled
Tumor-Agnostic

Neoplasms

NCT05027633 2026-03-20

Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)

M.D. Anderson Cancer Center

Phase 2 Recruiting
35 enrolled
Tumor-Agnostic

Carcinoma, Squamous Cell

NCT04361708 2025-10-01

I-FLOAT

University of Chicago

Phase 1 Recruiting
54 enrolled
Tumor-Agnostic

Adenocarcinoma

NCT07018570 2025-08-26

An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma

National Cancer Center Hospital East

Phase 2 Recruiting
26 enrolled
Tumor-Agnostic

Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡